Can bevacizumab administered together with beta radiation in treatment of pterygium play a role in additive effect and/or treatment of the side effects?
Pterygium is one of corneal-conjunctival pathologies that are frequently encountered by ophthalmologists. Its etiology, pathogenesis and treatment have been caused controversy for many years and remain as a problem, which is yet to be fully enlightened. The main treatment of pterygium is surgery. Th...
Main Authors: | Yasemin Benderli Cihan, Fatma Bagci |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Turaz Bilim
2019-03-01
|
Series: | Medicine Science |
Subjects: | |
Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=296372 |
Similar Items
-
Subconjunctival Bevacizumab Injection in Treatment of Pterygium
by: Mohammad Reza Besharati, et al.
Published: (2011-03-01) -
Subconjunctival Bevacizumab Injection in Treatment of Pterygium
by: Mohammad Reza Besharati, et al.
Published: (2011-03-01) -
Subconjunctival Bevacizumab for Primary Pterygium Excision; a Randomized Clinical Trial
by: Mohammad-Reza Razeghinejad, et al.
Published: (2014-01-01) -
Comparative study of pterygium surgery combined with bevacizumab or mitomycin C
by: Qi-Bin Xu, et al.
Published: (2013-12-01) -
Combined sutureless gluefree conjunctival autograft with subconjunctival bevacizumab for treatment of primary pterygium
by: Mona M Aly, et al.
Published: (2017-01-01)